Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve

Pharmacol Res. 2017 May:119:265-271. doi: 10.1016/j.phrs.2017.02.006. Epub 2017 Feb 16.

Authors

Cristina Scavone¹, Liberata Sportiello², Liberato Berrino¹, Francesco Rossi¹, Annalisa Capuano¹

Affiliations

¹ Department of Experimental Medicine, Section of Pharmacology "L. Donatelli", University of Campania Region "Luigi Vanvitelli", Via L. de Crecchio, 7, 80138 Napoli, Italy.
² Department of Experimental Medicine, Section of Pharmacology "L. Donatelli", University of Campania Region "Luigi Vanvitelli", Via L. de Crecchio, 7, 80138 Napoli, Italy. Electronic address: liberata.sportiello@unina2.it.

PMID: 28214611
DOI: 10.1016/j.phrs.2017.02.006

No abstract available

Publication types

Editorial

MeSH terms

Biosimilar Pharmaceuticals / therapeutic use*
European Union
Humans

Substances

Biosimilar Pharmaceuticals